C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer

被引：0
|
作者：
Tsakonas, G. [1 ]
Hirsch, F. R. [2 ]
Ekman, S. [1 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
c-Met; non-small cell lung cancer; early stage;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-070
引用
收藏
页码：S2124 / S2125
页数：2
相关论文
共 50 条
  • [31] Nomogram Predicting the Prognosis of Patients with Surgically Resected Stage IA Non-small Cell Lung Cancer
    Deng, Xu-Feng
    Dai, Yin
    Liu, Xiao-Qing
    Qi, Huang-Zhi
    Zhou, Dong
    Zheng, Hong
    Li, Jiang
    Liu, Quan-Xing
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 14 (02) : 376 - 386
  • [32] Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer
    Jazieh, AR
    Hussain, M
    Howington, JA
    Spencer, HJ
    Husain, M
    Grismer, JT
    Read, RC
    ANNALS OF THORACIC SURGERY, 2000, 70 (04): : 1168 - 1171
  • [33] MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis
    Liang, Hongge
    Wang, Mengzhao
    ONCOTARGETS AND THERAPY, 2020, 13 : 2491 - 2510
  • [34] Prognostic factors for surgically resected non-small cell lung cancer with cavity formation
    Shigefuku, Shunsuke
    Kudo, Yujin
    Yunaiyama, Daisuke
    Matsubayashi, Jun
    Park, Jinho
    Nagao, Toshitaka
    Shimada, Yoshihisa
    Saji, Hisashi
    Hagiwara, Masaru
    Okano, Tetsuya
    Kakihana, Masatoshi
    Kajiwara, Naohiro
    Ohira, Tatsuo
    Ikeda, Norihiko
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 973 - +
  • [35] Prognostic role of nitrotyrosines in surgically resected non-small cell lung cancer (NSCLC)
    Toschi, L.
    Colombo, P.
    Soldani, C.
    Giordano, L.
    Finocchiaro, G.
    Siracusano, L.
    Gianoncelli, L.
    Incarbone, M.
    Destro, A.
    Alloisio, M.
    Terracciano, L.
    Varella-Garcia, M.
    Cappuzzo, F.
    Roncalli, M.
    Viola, A.
    Santoro, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Prognostic Factors for Surgically Resected Non-Small Cell Lung Cancer with Cavity Formation
    Shigefuku, S.
    Kudo, Y.
    Yunaiyama, D.
    Matsubayashi, J.
    Park, J.
    Nagao, T.
    Shimada, Y.
    Hagiwara, M.
    Saji, H.
    Okano, T.
    Kakihana, M.
    Kajiwara, N.
    Ohira, T.
    Ikeda, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2408 - S2408
  • [37] Impact of Previous Malignancy on Outcome in Surgically Resected Non-Small Cell Lung Cancer
    Nakao, Keita
    Anraku, Masaki
    Karasaki, Takahiro
    Kitano, Kentaro
    Nagayama, Kazuhiro
    Sato, Masaaki
    Nakajima, Jun
    ANNALS OF THORACIC SURGERY, 2019, 108 (06): : 1671 - 1677
  • [38] The elderly patient with surgically resected non-small cell lung cancer - A distinct situation?
    Sterlacci, William
    Stockinger, Richard
    Schmid, Thomas
    Bodner, Johannes
    Hilbe, Wolfgang
    Waldthaler, Christian
    Oberaigner, Wilhelm
    Tzankov, Alexandar
    Fiegl, Michael
    EXPERIMENTAL GERONTOLOGY, 2012, 47 (03) : 237 - 242
  • [39] Telisotuzumab vedotin monotherapy in patients with previously treated c-Met plus advanced non-small cell lung cancer
    Horinouchi, Hidehito
    Goldman, J. W.
    Moiseenko, F.
    Cicin, I.
    Filippova, E.
    Bar, J.
    Tomasini, P.
    Ocampo, C.
    Sullivan, D.
    Maag, D.
    Motwani, M.
    Jin, J.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2022, 33 : S502 - S502
  • [40] Predictive survival markers in patients with surgically resected non-small cell lung carcinoma
    Moldvay, J
    Scheid, P
    Wild, P
    Nabil, K
    Siat, J
    Borrelly, J
    Marie, B
    Farré, G
    Labib, T
    Pottier, G
    Sesboüé, R
    Bronner, C
    Vignaud, JM
    Martinet, Y
    Martinet, N
    CLINICAL CANCER RESEARCH, 2000, 6 (03) : 1125 - 1134
12345